Trials / Conditions / Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
3 registered clinical trials studyying Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure wi NCT06712030 | Puerta de Hierro University Hospital | Phase 3 |
| Completed | Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyr NCT06393465 | Pfizer | — |
| Completed | Prevalence and Characteristics of Transthyretin Amyloidosis in Patients With Left Ventricular Hypertrophy of U NCT03842163 | Pfizer | — |